SEC Form 5 · accession 0000899243-18-003953
Wave Life Sciences, Inc. · WVE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory L. Verdine
Director
Period of report
Dec 31, 2017
Accepted (ET)
Feb 14, 2018 · 7:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001631574
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Aug 7, 2017 | G | 75,040 | $0.00 | D | 75,039 | D |
Table II — derivative securities
No Table II lines on this filing.